SectorMedical instruments
Established Date10/03/2014
Listing Date12/06/2020
ExchangeNASDAQ Stock Exchange
Full-time Employees667
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressNo. 5
Xingdao Ring Road North
International Bio Island
Guangzhou
510005 The People’s Republic of China
BusinessProvides sequencing cancer therapy selection services.
IntroductionBurning Rock Medicine LLC was incorporated in the Cayman Islands on March 10, 2014 and focuses on the development of innovative, reliable and clinically valuable cancer companion diagnostic and early detection products. The company's business and R&D directions mainly cover: 1. Precise medical detection of cancer patients; 2. Biomarker and companion diagnostic cooperation of global anti-tumor drug companies; 3. Early detection of multiple cancer types based on liquid biopsy. Burning Rock Medicine was awarded the first certificate of China's tumor NGS detection kit issued by the National Medical Products Administration (NMPA) in July 2018, which is a milestone in the field of in vitro diagnosis. The laboratory located in Guangzhou, China has passed the technical audit of the "High-throughput Sequencing Laboratory" issued by the Guangdong Provincial Clinical Laboratory Center, and has obtained the CLIA and CAP laboratory quality system qualification certification in the United States; the laboratory located in California, the United States has also obtained the CLIA and CAP laboratory quality system qualification certification. The company will continue to devote itself to the development of innovative and reliable NGS detection products to promote the development of tumor precision medicine.
